No consensus about consensus?

by Ludwig Kappos
Published 2021-08-01

Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results

by Jeffrey A. Cohen, Nadia Tenenbaum, Alit Bhatt, Ying Zhang, Ludwig Kappos
Published 2019-09-01

Impact of complement activation on clinical outcomes in multiple sclerosis

by Christian W. Keller, Johanna Oechtering, Heinz Wiendl, Ludwig Kappos, Jens Kuhle, Jan D. Lünemann
Published 2021-04-01

Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases

by Jeremias Motte, Janina Kneiphof, Katrin Straßburger-Krogias, Kalliopi Pitarokoili, Anna Lena Fisse, Ludwig Kappos, Ralf Gold
Published 2019-08-01

Death Anxiety and Attitudes towards Death in Patients with Multiple Sclerosis: An Exploratory Study

by Jara Francalancia, Paraskevi Mavrogiorgou, Georg Juckel, Tina Mitrovic, Jens Kuhle, Yvonne Naegelin, Ludwig Kappos, Pasquale Calabrese
Published 2021-07-01

Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE

by Ralf Gold, Douglas L. Arnold, Amit Bar-Or, Robert J. Fox, Ludwig Kappos, Chongshu Chen, Becky Parks, Catherine Miller
Published 2020-05-01

Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+ T Cells of Patients with Relapsing-Remitting Multiple Sclerosis

by Maria Meira, Claudia Sievers, Francine Hoffmann, Maria Rasenack, Jens Kuhle, Tobias Derfuss, Ludwig Kappos, Raija L. P. Lindberg
Published 2014-01-01

Efficacy and Safety of Fingolimod in an Unselected Patient Population.

by Maria Rasenack, Jonathan Rychen, Michaela Andelova, Yvonne Naegelin, Christoph Stippich, Ludwig Kappos, Raija L P Lindberg, Till Sprenger, Tobias Derfuss
Published 2016-01-01

Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFNβ-therapy.

by Matthias Mehling, Stefanie Fritz, Patricia Hafner, Dominik Eichin, Tomomi Yonekawa, Thomas Klimkait, Raija L P Lindberg, Ludwig Kappos, Christoph Hess
Published 2013-01-01

Blood neurofilament light as a potential endpoint in Phase 2 studies in MS

by Maria Pia Sormani, Dieter A. Haering, Harald Kropshofer, David Leppert, Uma Kundu, Christian Barro, Ludwig Kappos, Davorka Tomic, Jens Kuhle
Published 2019-06-01

Imaging multiple sclerosis pathology at 160 μm isotropic resolution by human whole-brain ex vivo magnetic resonance imaging at 3 T

by Matthias Weigel, Peter Dechent, Riccardo Galbusera, Erik Bahn, Govind Nair, Po-Jui Lu, Ludwig Kappos, Wolfgang Brück, Christine Stadelmann, Cristina Granziera
Published 2021-07-01

Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination

by Ludwig Kappos, Stanley Cohan, Douglas L. Arnold, Randy R. Robinson, Joan Holman, Sami Fam, Becky Parks, Shan Xiao, Wanda Castro-Borrero
Published 2021-02-01

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

by Bernard Uitdehaag, Cris Constantinescu, Peter Cornelisse, Douglas Jeffery, Ludwig Kappos, David Li, Magnhild Sandberg-Wollheim, Anthony Traboulsee, Elisabetta Verdun, Victor Rivera
Published 2011-01-01

Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).

by Heinz Wiendl, Helmut Butzkueven, Ludwig Kappos, Maria Trojano, Fabio Pellegrini, Dominic Paes, Annie Zhang, Shibeshih Belachew, Tysabri® Observational Program (TOP) Investigators
Published 2016-01-01

Evolution of Cortical and White Matter Lesion Load in Early-Stage Multiple Sclerosis: Correlation With Neuroaxonal Damage and Clinical Changes

by Ramona-Alexandra Todea, Ramona-Alexandra Todea, Po-Jui Lu, Po-Jui Lu, Mario Joao Fartaria, Mario Joao Fartaria, Mario Joao Fartaria, Guillaume Bonnier, Renaud Du Pasquier, Gunnar Krueger, Meritxell Bach Cuadra, Meritxell Bach Cuadra, Marios Nikos Psychogios, Ludwig Kappos, Ludwig Kappos, Jens Kuhle, Cristina Granziera, Cristina Granziera
Published 2020-09-01

Improving Accuracy of Brainstem MRI Volumetry: Effects of Age and Sex, and Normalization Strategies

by Laura Sander, Laura Sander, Antal Horvath, Simon Pezold, Simon Andermatt, Michael Amann, Tim Sinnecker, Tim Sinnecker, Tim Sinnecker, Maria J. Wendebourg, Maria J. Wendebourg, Eva Kesenheimer, Eva Kesenheimer, Özgür Yaldizli, Özgür Yaldizli, Ludwig Kappos, Ludwig Kappos, Cristina Granziera, Cristina Granziera, Jens Wuerfel, Philippe Cattin, Regina Schlaeger, Regina Schlaeger
Published 2020-12-01

No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score–matched comparison with every-4-week dosing in patients enrolled in the Tysabri Obser...

by Helmut Butzkueven, Ludwig Kappos, Tim Spelman, Maria Trojano, Heinz Wiendl, Ray Su, Shirley Liao, Robert Hyde, Stephanie Licata, Pei-Ran Ho, Nolan Campbell
Published 2021-09-01

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients.

by Michael Osthoff, Mira Katan, Felix Fluri, Philipp Schuetz, Roland Bingisser, Ludwig Kappos, Andreas J Steck, Stefan T Engelter, Beat Mueller, Mirjam Christ-Crain, Marten Trendelenburg
Published 2011-01-01

Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.

by Katrin Weier, Iris K Penner, Stefano Magon, Michael Amann, Yvonne Naegelin, Michaela Andelova, Tobias Derfuss, Christoph Stippich, Ernst-Wilhelm Radue, Ludwig Kappos, Till Sprenger
Published 2014-01-01

Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)

by Nicolas Collongues, Jens Kuhle, Charidimos Tsagkas, Julien Lamy, Nicolas Meyer, Christian Barro, Katrin Parmar, Michael Amann, Jens Wuerfel, Ludwig Kappos, Thibault Moreau, Jerome deSeze
Published 2021-02-01